Confirmed Sessions Offering Continuing Education Credits
Wednesday, September 12
- Education Session 01: Characterization and Classification of Cancers with Radiomics, Pathomics, and Deep Learning
- EducationSession 04: Mitochondrial Metabolism and Imaging
- Dive Into Deep Biology of Infections (IOI)
Total CME: 4.5
Total VOICE: 4.5
Total SAM: 4
Thursday, September 13
- Brain of fire? What is neuroinflammation imaging and what can it tell us about brain disease
- Scientific Session 03: Oncology: Preclinical Imaging 1 MRI
- Scientific Session 07: Oncology: Preclinical Imaging 2 Optical
Total CME: 4.5
Total VOICE: 4.5
Total SAM: 4
Friday, September 14 (CME Day)
- PSMA Molecular Imaging of Prostate Cancer
- Therapies – theranostics, drug development and innovation
- Imaging Neuroinflammation Beyond TSPO
- State-of-the Art in Cardiovascular Molecular Imaging from Bench to Bedside
- Plenary Session 3
- Scientific Session 09: Instrumentation 1 (Image-guided surgery)
- Scientific Session 10; Cardiology
- Scientific Session 11: Oncology: Preclinical Imaging 3 Multimodal/others
- Scientific Session 12: Oncology: Probes and Targets 3/ Therapy monitoring/Theranostics
- Scientific Session 13: Oncology: First-in-Human & Clinical Studies
- Scientific Session 14: Machine Learning
- Scientific Session 15: Metabolic Disease
- Scientific Session 16: Oncology: Preclinical Imaging 4 General/Therapy
- Scientific Session 17: Oncology: Probes and Targets 4 peptide/nucleotide/antibody
- Scientific Session 18: Neuroscience 1 PET/SPECT
Total CME: 21.75
Total VOICE: 21.75
Total SAM: 21
Saturday, September 15
- Scientific Session 21: Oncology: Probes and Targets 5 small chemistry/intrinsic
- Scientific Session 26: Oncology: Preclinical Imaging 6 PET/SPECT 2
Total CME: 3
Total VOICE: 3
Total SAM: 3
Overall Program Objectives
The World Molecular Imaging Congress (WMIC) serves as an excellent opportunity for researchers and clinician-scientists from around the globe to share their discoveries in the applications of Molecular Imaging for effective diagnosis, staging and treatment of diseases and injury.
The goal for WMIC is to allow clinicians the opportunity to stay up to date in their clinical practice or within a specific specialty. By attending the WMIC scientists and researchers advance their work and benefit from presenting their results and learning of new advances from the formal and informal scientific exchange of ideas in the advances and applications of Molecular Imaging. The WMIC will cover Molecular Imaging advances that include new research findings and applications of Molecular Imaging.
Overall Learning Objectives
Upon completion of this program participants should be able to:
- Evaluate the strength and weakness of each major imaging modality for molecular imaging, and identify novel hybrid imaging techniques in the field.
- Recognize common principles behind molecular imaging probes for each individual imaging modality, as well as the potential of multi-modality probes.
- Recognize the potential of molecular imaging for depicting and following specific molecular and cellular processes in vivo.
- Describe the stages of molecular imaging investigation which include identifying specific biological problems and identify in vitro and in vivo molecular imaging techniques to resolve these problems.
- Evaluate the potential, strengths and weaknesses of molecular imaging for specific organs and major diseases.
- Describe the principles of molecular imaging techniques for guiding and assessing therapeutic interventions, including drug development and therapy.
- Recognize the potential, strengths and weaknesses of specific molecular imaging for preclinical, clinical, and translational research.
Physician: Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Society of Nuclear Medicine and Molecular Imaging Inc. and the World Molecular Imaging Society. The Society of Nuclear Medicine and Molecular Imaging, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The Society of Nuclear Medicine and Molecular Imaging designates this live educational activity for attendees to receive AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.